---
$id: https://graph.org.ai/products/commodity/51263128
$type: Product
source: UNSPSC
code: "51263128"
title: "Nipradilol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nipradilol

**UNSPSC Code**: 51263128
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H22N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVM336I71Y, chemically known as 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2h-1-benzopyran but generally known as nipradilol, which bears US NIH Compound Identifier 72006. European Medicines Agency schedules Nipradilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12423MIG. The term NIPRADILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). NIPRADILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nipradilol under HS 29329985 and SITC 51569. As of Q4 2014, NIPRADILOL remains the US FDA Preferred Term for this commodity. Nipradilol bears US NLM identifiers UMLS ID C0132531 and NCI Concept Code C76555. SMILES: O1CC(O[N](=O)O)CC2C1C(OCC(O)CNC(C)C)CCC2.

